Specialty control plasma sales will grow through 2036, led by factor viii concentrate at 55% of the type segment in 2026. The market was valued at USD 11.05 billion in 2025 and is expected to be worth USD 21.86 billion by 2036, creating an incremental opportunity of USD 10.11 billion.